Home > News > PGI research may help lower drug dosage
July 9th, 2007
PGI research may help lower drug dosage
Abstract:
In future, people suffering from tuberculosis (TB), cardiovasucular diseases, hypertension and other chronic diseases may not have to take drugs daily for the rest of their lives. A path breaking pre-clinical research by a team of doctors at the PGI has established a system of sustained drug delivery through nanotechnology.
The system involves encapsulating the drug in nanoparticles taken from synthetic polymers. This ensures that the drug stays in the plasma and the organs for a longer period. Secondly, since the frequency of taking drugs comes down, lesser drugs are used.
Source:
cities.expressindia.com
Bookmark:
| Related News Press |
Nanomedicine
New molecular technology targets tumors and simultaneously silences two ‘undruggable’ cancer genes August 8th, 2025
New imaging approach transforms study of bacterial biofilms August 8th, 2025
Cambridge chemists discover simple way to build bigger molecules – one carbon at a time June 6th, 2025
Electrifying results shed light on graphene foam as a potential material for lab grown cartilage June 6th, 2025
Announcements
Decoding hydrogen‑bond network of electrolyte for cryogenic durable aqueous zinc‑ion batteries January 30th, 2026
COF scaffold membrane with gate‑lane nanostructure for efficient Li+/Mg2+ separation January 30th, 2026
 |
||
 |
||
| The latest news from around the world, FREE | ||
 |
||
|
|
||
| Premium Products | ||
 |
||
|
Only the news you want to read!
Learn More |
||
 |
||
|
Full-service, expert consulting
Learn More |
||
|
|
||